RARE

ULTRAGENYX PHARMACEUTICAL INC

Healthcare | Mid Cap

-$1.18

EPS Forecast

$168.1

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2025-12-31
ALKSAlkermes PlcBMRNBiomarin Pharmaceutical IncALNYAlnylam Pharmaceuticals IncIONSIonis Pharmaceuticals IncSRPTSarepta Therapeutics IncJAZZJazz Pharmaceuticals PlcNKTRNektar TherapeuticsPAHCPhibro Animal Health Corp